These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20012939)

  • 1. Increased risk of serious infections in women with osteopenia or osteoporosis treated with denosumab.
    Toulis KA; Anastasilakis AD
    Osteoporos Int; 2010 Nov; 21(11):1963-4. PubMed ID: 20012939
    [No Abstract]   [Full Text] [Related]  

  • 2. Increasing options for the treatment of osteoporosis.
    Khosla S
    N Engl J Med; 2009 Aug; 361(8):818-20. PubMed ID: 19671654
    [No Abstract]   [Full Text] [Related]  

  • 3. Denosumab-related osteonecrosis of the jaws.
    Kyrgidis A; Toulis KA
    Osteoporos Int; 2011 Jan; 22(1):369-70. PubMed ID: 20306021
    [No Abstract]   [Full Text] [Related]  

  • 4. Denosumab, osteoporosis, and prevention of fractures.
    Kiechl S; Willeit J; Schett G
    N Engl J Med; 2009 Nov; 361(22):2188-9; author reply 2190-1. PubMed ID: 19940304
    [No Abstract]   [Full Text] [Related]  

  • 5. [Innovations in the treatment of osteoporosis].
    Tsourdi E; Hofbauer LC
    Dtsch Med Wochenschr; 2011 Dec; 136(48):2458-60. PubMed ID: 22109575
    [No Abstract]   [Full Text] [Related]  

  • 6. [Denosumab--a new efficient osteoporosis therapy].
    Rejnmark L; Vestergaard P; Mosekilde L
    Ugeskr Laeger; 2011 Jan; 173(5):346-9. PubMed ID: 21276398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
    Wensel TM; Iranikhah MM; Wilborn TW
    Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteonecrosis of the jaw after zoledronic acid and denosumab treatment.
    Fusco V; Galassi C; Berruti A; Ciuffreda L; Ortega C; Ciccone G; Angeli A; Bertetto O
    J Clin Oncol; 2011 Jun; 29(17):e521-2; author reply e523-4. PubMed ID: 21537047
    [No Abstract]   [Full Text] [Related]  

  • 9. Population pharmacokinetic meta-analysis of denosumab in healthy subjects and postmenopausal women with osteopenia or osteoporosis.
    Sutjandra L; Rodriguez RD; Doshi S; Ma M; Peterson MC; Jang GR; Chow AT; Pérez-Ruixo JJ
    Clin Pharmacokinet; 2011 Dec; 50(12):793-807. PubMed ID: 22087866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denosumab (Prolia): A new option in the treatment of osteoporosis.
    Belavic JM
    Nurse Pract; 2011 Jan; 36(1):11-2. PubMed ID: 21173630
    [No Abstract]   [Full Text] [Related]  

  • 11. Osteonecrosis of the jaw in a patient on Denosumab.
    Aghaloo TL; Felsenfeld AL; Tetradis S
    J Oral Maxillofac Surg; 2010 May; 68(5):959-63. PubMed ID: 20149510
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteonecrosis of the jaw.
    Drozdzowska B
    Endokrynol Pol; 2011; 62(1):88-92. PubMed ID: 21365586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapies to manage bone loss-associated diseases: a quest for the perfect benefit-to-risk ratio.
    Valverde P
    Curr Med Chem; 2008; 15(3):284-304. PubMed ID: 18288984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis medications and your dental health.
    J Am Dent Assoc; 2011 Nov; 142(11):1320. PubMed ID: 22041419
    [No Abstract]   [Full Text] [Related]  

  • 15. Denosumab (prolia) for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2010 Oct; 52(1349):81-2. PubMed ID: 21045756
    [No Abstract]   [Full Text] [Related]  

  • 16. Denosumab in men receiving androgen-deprivation therapy for prostate cancer.
    Smith MR; Egerdie B; Hernández Toriz N; Feldman R; Tammela TL; Saad F; Heracek J; Szwedowski M; Ke C; Kupic A; Leder BZ; Goessl C;
    N Engl J Med; 2009 Aug; 361(8):745-55. PubMed ID: 19671656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical use of denosumab for the treatment for postmenopausal osteoporosis.
    Lewiecki EM
    Curr Med Res Opin; 2010 Dec; 26(12):2807-12. PubMed ID: 21050058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denosumab for treatment of postmenopausal osteoporosis.
    Chitre M; Shechter D; Grauer A
    Am J Health Syst Pharm; 2011 Aug; 68(15):1409-18. PubMed ID: 21785030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
    Cummings SR; San Martin J; McClung MR; Siris ES; Eastell R; Reid IR; Delmas P; Zoog HB; Austin M; Wang A; Kutilek S; Adami S; Zanchetta J; Libanati C; Siddhanti S; Christiansen C;
    N Engl J Med; 2009 Aug; 361(8):756-65. PubMed ID: 19671655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More about osteonecrosis.
    Finkelman RD; Clemons M; Bouganim N
    J Am Dent Assoc; 2011 Apr; 142(4):371-2; author reply 372-4. PubMed ID: 21454842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.